Objective: As bradykinin (BYK) relaxes conduit (EPA) and resistance (RPA) pulmonary arteries from both perinatal and adult lungs, we investigated whether this vasodilator's relaxation-mechanisms were altered during perinatal development, differed between EPA and RPA and differed with other endothelium-dependent vasodilators, acetyicholine (ACH) and substance P (SP). Methods: Arteries from mature foetal (5 days), neonatal (¯5 min), newborn (60-84 h) and adult pigs ($6 months) were isolated, mounted for in vitro isometric force recording, activated with PGF (30 mmol / l) and relaxed with BYK (10 pmol / l-1 mmol / l), SP (10 pmol / l-0.1 mmol / l) or ACH 2a
Introduction
life (60-84 h old); NE, neonatal with partially inflated lungs (#5 min old); NO, nitric oxide; NOS, nitric oxide synthase; PG, prostaglandins;
There is consensus in the literature that bradykinin RPA, muscular resistance-type small intrapulmonary arteries; SP, sub-(BYK) can dilate pulmonary arteries of the foetus [1] [2] [3] stance P *Corresponding author. and the neonate [1, 4, 5] with the possible exception of However, with increasing age, BYK loses its vasodilator large, elastic, conduit-type pulmonary arteries [1, 6] , in capacity in ovine pulmonary arteries [2, 10, 11, 16] . Therewhich this response emerges only after the first rapid phase fore, porcine pulmonary arteries were chosen, taking of extra-uterine pulmonary adaptation has been completed advantage of the fact that BYK, unlike other endothelium- [7] . These relaxations appear to be endothelium-dependent dependent vasodilators (acetylcholine, ACH; substance P, [1] (see however Ref. [8] ) and involve two endothelium-SP), elicits relaxation in both large conduit-type and small derived relaxing factors, namely nitric oxide (EDNO) and resistance-type arteries at every age [1] . However, whereprostaglandins (EDPG), the latter to a varying extent ver possible, comparisons were made with the mechanisms [2, 5, [9] [10] [11] [12] . It remains unclear from these studies whether by which ACH-or SP-induced relaxations in arteries of the relative contributions of EDNO and EDPG to BYKcomparable size and age. induced vasodilatation were similar in the foetus, the neonate and the adult. Several lines of evidence, either direct or indirect, suggest otherwise. Firstly, the relaxant 2. Material and methods effects of BYK in adult porcine pulmonary arteries in vitro have been shown to be independent of EDPG-synthesis 2.1. Animals and to be partly dependent on both EDNO and an endothelium-derived hyperpolarising factor (EDHF) [13] .
Large elastic conduit-type (EPA) and small muscular These observations contrast with those obtained in perresistance-type (RPA) pulmonary arteries were obtained fused piglet lungs where L-NAME or indomethacin each from mature foetal (5 days before term), neonatal (¯5 min could almost completely abrogate the vasodilator response old, lungs partially inflated), new-born (60-84 h old) and to BYK [5] . However, extrapolations from intact lung adult ($6 months old) mixed breed pigs (Landrace / Large studies to experiments on isolated arteries are difficult to White) and mounted for isometric force recording as make: arterial size may profoundly influence the type of described previously [1] . Perinatal piglets weighed beendothelium-derived relaxing factor released with smaller, tween 0.5 and 2.5 kg. All animal experimentation was resistance-type arteries, utilising less EDNO and more of carried out as described in the license issued by the Home the as yet uncharacterised EDHF [14, 15] . More specifically Office in accordance with the Animals (Scientific Profor large and small pulmonary arteries, numerous other cedures) Act 1986. differences have been documented already [16] [17] [18] [19] [20] . Secondly, BYK relaxations in conduit-type elastic perinatal 2.2. Experimental protocols and calculations arteries appear to be much more prone to desensitisation than in similar adult arteries [1] . Thirdly, the amounts and After mounting, all arteries were stretched transversally 1 activities of nitric oxide synthase (NOS) and cyclo-oxyfor maximal isometric force to K 5125 mmol / l (dimengenase (COX) in pulmonary arteries and lungs change sions and amplitude of the contraction in Table 1 ). All considerably within the perinatal period and between the experimental protocols were as described previously [1] . In perinatal period and adult life [21] [22] [23] [24] [25] [26] . Fourthly, BYK a first series of experiments, cumulative concentrationreleases increasing amounts of prostacyclin from ovine response relations (CCRR) to BYK (acetate salt, Sigma, 10 pulmonary arteries as determined between the mature pmol / l to 1 mmol / l, log unit steps, except foetal and foetal state and 4 weeks postnatally [26] . Fifthly, inhibition neonatal EPA, single application of 1 mmol / l) were of prostaglandin-synthesis in ovine arteries has varying obtained from PGF (30 mmol / l, tromethamine salt,
effects on the BYK-relaxations, depending on postnatal Cayman Chemical) or K 5125 mmol / l contracted vesage [10] . sels, quantified against the maximal relaxation induced by From this literature survey, it is unclear whether the papaverine (100 mmol / l, Sigma) and fitted to a sigmoidal relaxations induced by BYK, which were shown to be relation yielding R (maximal relaxation) and pD max 2 similar in foetal, neonatal, new-born and adult resistance (concentration for half-maximal relaxation) [1] . A protocol pulmonary arteries [1] , were mediated by identical underemploying a single rather than cumulative concentrations lying mechanisms. It is also unclear whether these mechaof BYK was applied in the EPA from foetal and neonatal nisms would be uniquely activated by BYK, or also by vessels as the former procedure resulted in transient other endothelium-dependent vasodilators and whether relaxations whereas the latter did not result in any relaxathere would be differences between conduit and resistance tions, probably due to ongoing desensitisation processes pulmonary arteries. It was the objective of the present [1] . In a second series of experiments, ACH (1 nmol / l to 1 paper to investigate, through pharmacological in vitro mmol / l, log unit steps) was added to PGF contracted 2a manipulation, the mechanisms through which BYK elicits new-born EPA and RPA and adult EPA. ACH does not relaxations in pulmonary arteries of the perinatal period relax adult RPA in a concentration-dependent manner [1] and to compare these mechanisms with those operating in and this observation was confirmed in the present study: in mature, adult arteries. The foetal ovine pulmonary circulaeight adult RPA a single application of ACH (1 mmol / l) tion has been extensively studied [2, 3, 8, [10] [11] [12] 21, 25, 26] .
yielded a small and unreproducible relaxation of 1368% but all these vessels relaxed to the subsequent application The level of spontaneous tone and the amplitude of the of 0.1 mmol / l BYK (5863%). ACH-induced relaxations PGF -induced contractions were expressed as percentage 2a 1
were not fitted to a sigmoidal relation as the profile of the of the amplitude of K 5125 mmol / l induced contractions effects was distinctly biphasic: relaxations at the lower obtained in the same tissues at the beginning and end of followed by contractions at the higher ($10 mmol / l) the experiment. Amplitudes of contractions and spontaconcentrations. In a third series of experiments, SP (10 neous tone were calculated from a baseline as obtained pmol / l to 0.1 mmol / l, log unit steps) was added to PGFfrom papaverine [1] . [27, 28] , 100 mmol / l, HCl-salt, Calbiochem) were added performed for indomethacin (BYK ), (Fig. 7) , for the (PG) 15-20 min before addition of PGF with paired control combination of indomethacin and L-NAME (BYK ) 2a (NO&PG) tissues (same animal) receiving vehicle. and for SKF525a. Table 2 a Effects of indomethacin, L-NAME and SKF525a on bradykinin-relaxations in pulmonary arteries 
Results

Initial observations
The circumference of EPA and RPA at the various ages, EPA and statistical analysis of differences, see Table 2 .
from foetal to postnatal life had little effect on the contractile parameters of the vessels studied and only maturation to adult life was accompanied by an increased values were significantly different from corresponding 1 contractile response to high K . values in the adult (a priori contrast, simple ANOVA). In this series of data, both the foetal and the new-born new-born and adult EPA (Fig. 7) . Indomethacin signifi-2). The amplitude of the PGF -induced contraction was 2a significantly (paired Student's t-test) increased in RPA from all ages but only in new-born EPA (see legend Fig.  2 ). L-NAME significantly attenuated BYK-induced relaxations in EPA by reducing R at all ages (Table 2 and Fig.   max 2). The attenuating effects of L-NAME on R in EPA max increased with age with significant differences between the foetal and the neonatal and between the foetal and adult stages ( Table 2 ). In the new-born, no reliable fit of the CCRR could be obtained. BYK showed a biphasic (NO) age-dependency being 0.56 in foetal EPA, 1.0 in neonatal EPA, and¯0.80 in EPA from older ages (Fig. 7) . In foetal and neonatal RPA, L-NAME respectively abolished and significantly attenuated BYK-induced relaxations by reducing R and shifting pD by respectively max 2 0.4 units and¯0.8 units (Table 2 and Fig. 2) . No statistically significant effects were noted in the adult. The attenuating effects of L-NAME on R in RPA decreased max with age with significant differences between the foetal and the neonatal and between the foetal and adult stages ( Table 2) . BYK decreased from 0.90 in foetal RPA to (NO) 0.20 in adult RPA (Fig. 7) . (Fig. 3 ) Combined application of L-NAME and indoemthacin to new-born and adult EPA completely inhibited the BYK- Fig. 2 . Effects of L-NAME (100 mmol / l) on BYK-relaxations in PGF2a induced relaxations (Fig. 3) . This protocol also inhibited contracted EPA and RPA from foetal, neonatal, new-born and adult lungs.
Combined application of L-NAME and indomethacin abrogates relaxations in EPA but not in postnatal RPA
relaxations after a single application of 1 mmol / l BYK in For N, effects of L-NAME on foetal and neonatal EPA and statistical foetal EPA (paired Student's t-test, from 3369% to analysis of differences, see Table 2 . L-NAME increased spontaneous tone significantly in foetal EPA (from 2463 to 3264%), neonatal EPA (from 21.960.4%, 4). As L-NAME already completely inhibited adult RPA ( Fig. 1 and Table 2 ). The attenuating effects of indomethacin on R depended on age with significant max differences between foetal and neonatal and between neonatal and adult stages (Table 1) . BYK was 20.09 (PG) in foetal RPA and was 0.20, 0.12 and 0.19 postnatally (neonatal, new-born and adult, respectively, Fig. 7 ).
3.2.2.
The age-dependency of the attenuating effects of L-NAME increases in EPA but decreases in RPA (Fig.  2 ) Fig. 3 . Effect of combined application of L-NAME (100 mmol / l) and Application of L-NAME (100 mmol / l) increased sponta- L-NAME and indomethacin completely attenuated the relaxation (Fig. 3) . As L-NAME already completely abolished relaxations in foetal RPA, this protocol was not performed in these vessels. BYK decreased from (NO&PG) 0.95 in neonatal RPA to 0.22 in new-born and 0.42 in adult RPA.
Complete abrogation of the relaxant response to BYK by combined application of L-NAME and indomethacin occurred while the sum of the contributions of EDNO and EDPG were larger (postnatal EPA, synergy) or smaller than unity (foetal EPA and neonatal RPA, amplification). In the latter case, the effect of combined NOS-and COXinhibition was larger than could be predicted from the To establish whether the vasodilatation by BYK after contracted arteries (respectively 4365 and 2863% in high K -contracted combined NOS-and COX-inhibition could be mediated by RPA and 7163 (17) and 8267% (7) in PGF -contracted RPA). BYK relaxed high K -contracted, foetal and neonatal BYK-CCRR to an extent greater than when each inhibitor RPA with significantly smaller R but similar senwas applied seperately. Application of L-NAME, SKF525a max sitivities (PD ) when compared with PGF -contracted and indomethacin resulted in a similar degree of attenua-2 2 a preparations (Fig. 4, legend) . There were no significant tion (Fig. 6, right panel) . relaxations any more in new-born and adult RPA. Thus the 1 effects of high K , whilst establishing a major contribution of hyperpolarisation for the relaxant effects of BYK in 3.3. Acetylcholine RPA, also revealed a further age-dependency of the mechanisms of BYK-relaxations in both EPA and RPA.
ACH at lower concentrations relaxed both EPA and RPA, whereas at higher concentrations ($10 mmol / l),
SKF525a inhibits BYK-relaxations in postnatal
contractions were recorded (Figs. 8 and 9 ). The age-RPA only in the presence of L-NAME (Figs. 5 and 6) dependency of the relaxant effects of ACH corroborated Having established that hyperpolarisation could play a earlier findings [1] : although relaxations were prominently role in BYK-relaxations, we tested whether a factor, present in new-born RPA, they were completely absent in synthesised through the cytochrome P450-pathway [27] , adult RPA (see also Section 2.2). was involved. The concentration of SKF525a used has Indomethacin did not have any significant effects on the been described to attenuate BYK-induced relaxations in relaxations induced by ACH in new-born RPA or in newporcine coronary arteries [28] . SKF525a did not influence born and adult EPA (results not shown). spontaneous tone in any of the arteries. Contractions Addition of L-NAME completely abolished ACH-relaxainduced by PGF (30 mmol / l) were reduced significantly tions in new-born EPA and RPA (Fig. 8 ), but had no 2a (paired Student's t-test) in foetal RPA (from 14169% to effects in adult EPA (Fig. 8) . Combined application of 87620%, 6) and adult RPA (from 13169% to 5769%, 6).
L-NAME and indomethacin significantly attenuated the SKF525a had no effects on BYK-induced relaxations in ACH-induced relaxations in adult EPA but did not abolish new-born and adult EPA (Fig. 5) . In new-born and adult them (Fig. 9) . statistical analysis of differences, see Table 2 .
3.4. Substance P still occurred which did not differ between the four groups of arteries tested. No change to this attenuation was The amplitude of the relaxant effects of SP increased observed when SP-induced relaxations were obtained in between new-born and adult EPA and RPA (Tables 3 and the presence of both L-NAME and indomethacin (Table 4 ). 4). New-born EPA and RPA were relaxed by a single application of 0.1 mmol / l SP in order to obtain a significant, although still highly transient, relaxation (Methods,
Discussion Section 2).
Indomethacin did not alter the CCRC to SP in adult EPA We have shown here that BYK utilises different endoand RPA, nor the relaxations to a single application of SP thelium-derived relaxing factors (EDNO, EDPG, EDHF) (0.1 mmol / l) in new-born EPA and RPA (results not shown). Addition of L-NAME (100 mmol / l) attenuated the relaxations to SP comparably in new-born and adult EPA and RPA (Table 3 ) but a significant degree of relaxation Fig. 7 . Age-dependence of contribution of EDNO and EDPG to BYKinduced relaxations (solid lines, RPA; dotted lines, EPA). Relative Fig. 6 . Effect of joint application of L-NAME (100 mmol / l) and contribution of EDNO (d,j, based on inhibitory effects of L-NAME, SKF525a (100 mmol / l), o or L-NAME (100 mmol / l) with SKFS25a (100 Table 2 , Fig. 2 , Section 2.2) or EDPG (s,h, based on inhibitory effects mmol / l) and indomethacin (10 mmol / l, n) compared with untreated of indomethacin, Table 2 and Fig. 1 ) to the total relaxant effect of BYK controls ȣ on BYK-relaxations in new-born (3) and adult (6) RPA.
(set at the value of 1 for each age and type of artery). stages which were compared with the adult state reflect the depending on the stage of lung maturation and growth and pulmonary circulation of the non-breathing but mature the type of pulmonary artery. These dependencies are foetus, the pulmonary circulation immediately after birth at unique for BYK as they are not mimicked by other the onset of breathing and of extra-uterine adaptation and endothelium-dependent vasodilators. The various perinatal after the first rapid phase of extra-uterine adaptation has Table 3 Effect of L-NAME (100 mmol / l) on relaxations induced by substance P CCRC / L-NAME 4462 9.760.0 ND: not determined, NB new born (60-84 h old): AD adult. a SA: single application; CCRC: cumulative concentration response curve; con, L-NAME: paired control and L-NAME-treated preparations. b Significant effect between control and L-NAME-treated preparations (paired Student t-test). Table 4 Effect of L-NAME (100 mmol / l) and indomethacin (10 mmol / l)) on relaxations induced by substance P been completed in the pig [7] . The choice of vessels at with BYK, releasing progressively increasing amounts of these different stages was governed by the criterion of prostacyclin with age [26] ). Different oxygen tensions comparable locations: RPA, by virtue of their similar in employed in Ref. [2] and in our study might influence vitro diameters at different ages (Table 1) , thus were experimental outcomes although BYK-CCRR in porcine obtained from comparable sites upstream from the alveoli; foetal RPA were not influenced by the prevailing oxygen similarly, EPA had comparable locations downstream for tension [1] as was the case for ovine foetal arteries [2] . the main pulmonary artery. Estimating, through isometric EDPG, released by BYK, appeared only to have a minor force, the contribution of various endothelium-derived auxiliary role for BYK-relaxations in RPA, but more so in relaxing factors requires firstly that it is established to what EPA as the phenomenon of EDNO / EDPG-synergy (see extent these factors are released in absence of BYK. This below) was prominent in the latter. A further significant was done by evaluating the effects of L-NAME, incontribution of EDPG's to endothelium-mediated vasodidomethacin and SKF525a on the amplitude of spontaneous latation seems to be absent in all porcine pulmonary and PGF -induced tone [31, 32] . We found that NO arteries as indomethacin did not influence ACH-or SP2a modifies both spontaneous and agonist-induced tone, deinduced relaxations. pending on age and arterial size / function. Possible mechaIn RPA, BYK-relaxations became progressively less nisms for this could be: (i) receptors for PGF [33] may sensitive to L-NAME with increasing age despite charac2a be distributed differently on the endothelium, depending teristics of relaxations in the absence of L-NAME (pD and   2 on age and vessel size / function; (ii) a varying and age-R ) being identical at all the stages of lung development max dependent excitability of EPA and RPA, possibly related to studied. This decrease of the primary (i.e. significant different electrophysiological properties [19, 34] . It is thus attenuation by sole application of L-NAME) dependence possible that NO, already released in absence of BYK in on EDNO for BYK-relaxations in RPA is the opposite of quantities sufficient to modulate isometric force, could that in EPA. Here, the primary dependence on EDNO is further potentiate the relaxant effects of BYK. This substantial (¯50%) and further raises in postnatal EPA, remains to be resolved. much larger than in corresponding RPA (Figs. 2 and 7) . Spontaneous or PGF -induced vasoconstrictor PG-reThese divergent dependencies on EDNO occur during a 2a lease was indicated by the indomethacin-induced attenuaperiod in which overall NOS-levels increase in porcine tion of basal tone in neonatal and new-born EPA and the lungs [24] . Except for the mature foetal stage, EPA relied attenuation of PGF -induced contractions in foetal RPA.
more on EDNO for endothelium-dependent relaxation than 2a
The latter can be explained by the autocrine release of PG RPA. This characteristic, described for adult, mature by PGF [35] . The converse occurred in new-born EPA vessels [14, 15] has here shown to be present in pulmonary 2a where indomethacin potentiated the response to PGF arteries from birth onward. However, the increasing depen2a indicating that at this age, a basal release of vasoconstrictor dence with postnatal age on EDNO in EPA and decreasing PG is accompanied by a PGF -induced release of vasodidependence on EDNO in RPA is unique for BYK. For 2a lator PG. However, PG-release in absence of BYK, ACH-induced relaxations in EPA, dependence on EDNO, although dependent on age and arterial size, is not likely to as judged from the decreasing attenuating effects of Lcontribute mechanically to BYK-relaxations as this release NAME (Fig. 8 ) decreased with age. Furthermore, in newhas only small mechanical effects and consists mainly of born RPA, ACH-relaxations were completely dependent on vasoconstrictor PG's.
EDNO (Fig. 8 ) and this at a time when the relaxations to The attenuation by SKF525a of the PGF -induced BYK were almost completely independent of EDNO 2a contractions in foetal and adult RPA remains currently (compare Fig. 2 with Fig. 8) . A further degree of heterounexplained. SKF525a has inhibitory effect on K -changeneity was shown by the effects of SP which did not Ca nels [36] , but K -channel blockade is usually associated show age-dependency for the attenuating effects of LCa with increased contractions [37] and furthermore, K -NAME and indomethacin and in which these attenuating Ca channels are only sparsely present in pulmonary myocytes effects were identical in RPA and EPA. [19, 34] .
The persistence of BYK-relaxations in presence of LThe contribution of EDPG to BYK-relaxations had the NAME and indomethacin in new-born and adult RPA does following characteristics: (i) it only occurred postnatally; not imply that EDNO is not released anymore by BYK at (ii) it explained typically¯20% of the relaxant effects in these ages. Rather, BYK stimulates the release of two, RPA but up to¯50% in EPA and (iii) it was delayed in mutually redundant endothelium-derived relaxing factors EPA until the completion of the first rapid phase of through duplicate pathways (Fig. 6) , a process which extra-uterine adaptation. These conclusions do not coremerges postnatally in RPA only. This conclusion is based 1 roborate earlier results obtained from sheep where inon the experiments with SKF525a and K 5125 mmol / l. domethacin attenuated BYK-relaxations in foetal small Similar to L-NAME and indomethacin in new-born and arteries [2] and where these attenuating effects became adult RPA, SKF525a on its own failed to attenuate BYKprogressively less with age in large elastic arteries [10] relaxations. The prominent attenuation of BYK-relaxations (this latter observation is, in itself, difficult to reconcile after combined NOS-and cytochrome P450-inhibition suggests that in RPA, upon inhibition of the synthesis of induced by ACH and SP. These comparisons were very NO or of a P450 metabolite, each factor alone could limited as BYK is the only endothelium dependent vasodialmost maintain BYK-induced vasodilatation at control lator which relaxes all types of pulmonary arteries at all levels and only the combined inhibition of both pathways ages. SF-induced relaxations, completely absent in the could disrupt relaxations. The postnatal developmental foetus and the neonate, become more prominent with aspects of the P450 isozyme responsible for the synthesis increasing age (Tables 3 and 4 ) whereas the relaxant of EDHF (P450 2C [38]) have not been studied but the responses to ACH, which are present perinatally, have expression of P450 isozymes appears to be increasing completely disappeared in adult RPA, even upon applicapostnatally [39, 40] . The persistence of ACH-induced relation of a single concentration of ACH (to bypass possible xations in adult EPA and of SP-induced relaxations in ongoing desensitisation processes). From these comparinew-born and in adult after combined application of L- sons, it appeared that BYK, in the porcine pulmonary NAME and indomethacin indicate that the localisation of a arteries, was the only endothelium-dependent vasodilator P450 / EDHF pathway is not restricted to RPA.
to (i) activate EDPG-pathways in RPA and EPA; (ii) The hyperpolarising nature of this P450 metabolite was display the phenomenon of synergy between EDNO and 1 confirmed with K 5125 mmol / l as the contractile agonist, EDPG in EPA; (iii) decrease its primary dependency on which inhibited BYK-relaxations in RPA from the new-EDNO with increasing maturation in RPA and (iv) lack the born stage onward. The emergence of this inhibition capacity to stimulate a non-EDNO / non-EDPG pathways in correlated with the primary dependence on L-NAME postnatal EPA. How different endothelial receptors can be becoming greatly reduced. The ineffectiveness of SKF525a selectively coupled to different intracellular pathways, on its own on BYK-relaxations made us anticipate that depending on development and vascular function needs 1 K 5125 mmol induced depolarisation would attenuate further investigation. rather than inhibit the response to BYK in RPA but it has
In conclusion, the mechanisms of BYK-relaxations are been shown in porcine EPA that part of the NO effects on unique for this vasodilator and are further characterised by smooth muscle can be mediated through K-channel depena spatial and temporal heterogeneity. Thus, it cannot be dent hyperpolarisation [13, 27] . The postnatal emergence of assumed that the mechanisms of agonist-induced endoa P450 metabolite-EDHF-contributing to the relaxant thelium-dependent vasodilatation are similar in the newly effects of BYK in RPA could thus be suggested.
born and in the adult. BYK appears to be an extremely A further difference between EPA and RPA was the adaptable endotheliumdependent vasodilator, perhaps well synergy of NO and PG, present in neonatal new-born and suited to accommodate the rapid changes in the regulation adult EPA [29, 41] . The labile nature of NO may necessitaof pulmonary blood flow that are required to take place te synergy as a more efficient way of myo-endothelial upon adaptation to extrauterine life. coupling in thick walled vessels, but it remains puzzling why such a phenomenon is only activated by BYK and not by ACH or SP. The opposite, amplification (neonatal RPA Note added in proof and foetal EPA, Section 3.2.3) remains equally unexplained.
While in proof, further experiments on foetal RPA have The use of BYK, and to a lesser extent ACH, in these revealed that the relaxations to SP (bolus-application) and developmental studies has revealed a novel phenomenon ACH (CCRC) are completely attenuated by L-NAME as existing in myo-endothelial coupling. Whereas previously are the relaxations to SP (bolus-application) in foetal EPA the relative contributions of EDPG, EDNO or EDHF to (Boels and Deutsch, unpublished). These results further BYK-induced endothelium-dependent relaxations were illustrate the significant changes of the mechanisms of thought to be a static property depending on species pulmonary, endothelium-dependent vasodilators brought differences (see Ref. [3] for a discussion), differences about by age, type of vessel and agonist. between vascular beds [42] (compare also responses in porcine pulmonary arteries with those in porcine coronary arteries [43] ) or arterial size / function (see Introduction), it Acknowledgements now becomes apparent that such changes can be much more dynamic and can fluctuate within days in the same This study was made possible through a grant of the arterial segment. The precise molecular arrangement and British Heart Foundation. control of these multiple pathways, remains to be investigated.
A further level of flexibility in which the EDNO-, References EDPG-and EDHF-pathways are being activated was uncovered by the experiments which compared, at similar induced endothelium-dependent relaxations with those
